RAB0520
Bovine IFNG / Interferon Gamma ELISA Kit
for serum, plasma and cell culture supernatants
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.32
UNSPSC Code:
41116158
Gene information:
bovine ... IFNG(281237)
Input:
sample type cell culture supernatant(s)
sample type serum
sample type plasma
sample type serum
sample type plasma
Species reactivity:
bovine
Storage temp.:
−20°C
Shipped in:
wet ice
species reactivity
bovine
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
input
sample type cell culture supernatant(s)
sample type serum
sample type plasma
assay range
inter-assay cv: <10%
intra-assay cv: <12%
sensitivity: 0.11 ng/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
bovine ... IFNG(281237)
General description
This ELISA antibody pair detects bovine Interferon Gamma.
Application
For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Other Notes
A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.
Please type the word sample in the text box provided for lot number.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Kawaljit Kaur et al.
Oncoimmunology, 7(5), e1426518-e1426518 (2018-05-04)
Therapeutic role of NK cells in solid tumors was challenged previously even though their role in hematological malignancies has clearly been established. Furthermore, functions and numbers of NK cells are greatly suppressed in oral cancer patients necessitating effective future NK
Greta Garrido et al.
Frontiers in pharmacology, 8, 595-595 (2017-10-24)
Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor - T cell interactions. Previous studies showed an
Craig D Platt et al.
The Journal of allergy and clinical immunology, 140(6), 1651-1659 (2017-02-14)
Leucine-rich repeat containing 8A (LRRC8A) is an ubiquitously expressed transmembrane protein with 17 leucine-rich repeats (LRRs) at its C-terminal end and is an essential component of the volume-regulated anion channel (VRAC), which controls cellular volume. A heterozygous mutation in LRRC8A that
Ryosuke Uchiyama et al.
Journal of immunology (Baltimore, Md. : 1950), 199(3), 1122-1130 (2017-07-05)
CD4
Krithika N Kodumudi et al.
Frontiers in immunology, 10, 1939-1939 (2019-09-03)
Patients with metastatic HER2 breast cancer (MBC) often become resistant to HER 2 targeted therapy and have recurrence of disease. The Panacea trial suggested that HER2 MBC patients were more likely to respond to checkpoint therapy if TIL were present
Related Content
Instructions
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service